HEALIUS LIMITED — Major Shareholding Notification 2018

Aug 29, 2018

Form 605

Corporations Act 2001 Section 671B

Notice of ceasing to be a substantial holder

To Company Name/ Scheme	Primary Health Care Limited
ACN/ARSN
1. Details of substantial holder (1) Name	Vinva Investment Management
ACN/ ARSN (if applicable)	147 934 263
The holder ceased to be a substantial holder on		28/08/2018
The previous notice was given to the company on		23/04/2018
The previous notice was dated 27/08/2018		19/04/2018

1. Changes in relevant interests

L. Unanged in relevant interests.
Particulars of each change in, or change in the nature of, a relevant interest of the substantial holder or an associate in voting securities of the company
or scheme, since the substantia

Person whose relevant interest changed	Nature of change (4)	Consideration given in relation to change (5)	Class (6) and number of securities affected	Person's votes affected
20/04/2018 - Vinva Investment 28/08/2018 Management	Acquisition of 6,470,298 shares	Consideration for Acquisition of Shares \$18,324,608	6,470,298 shares	6,470,298 shares
	Disposal of 8,337,714 shares	of Shares \$23,036,326	8 337,714 shares	8.337.714 shares
			42,985 shares	42,985 shares
			Transfer in 42,985 shares	Consideration for Disposal

3. Changes in association

The persons who have become associates (3) of, ceased to be associates of, or have changed the nature of their association (7) with, the substantial holder in relation to voting interests in the company or scheme are as follows:

Name and ACN/ ARSN (if applicable)	Nature of association
N/k

4. Addresses

The addresses of persons named in this form are as follows:

	Name		Address
	Vinva Investment Management		Level 13, 10 Bridge Street, Sydney, NSW 2000
Signature	Print name Sign here	Robert Cochrane	Capacity Chief Operating Officer Date

DIRECTIONS

• If there are a number of substantial holders with similar or related relevant interests (eg. a corporation and its related corporations, or the manager and trustee of an equity
  trust), the names could be included in an ann $(1)$
• See the definition of "relevant interest" in sections 608 and 671B(7) of the Corporations Act 2001. $(2)$
• See the definition of "associate" in section 9 of the Corporations Act 2001. $(3)$
• Include details of: $(4)$
• any relevant agreement or other circumstances because of which the change in relevant interest occurred. If subsection 671B(4) applies, a copy of any $(a)$ divergence in the terms of any relevant agreement, and a statement by the person giving full and accurate details of any contract, scheme or
  document setting out the terms of any relevant agreement, and a statement certify
• any qualification of the power of a person to exercise, control the exercise of, or influence the exercise of, the voting powers or disposal of the securities to
  which the relevant interest relates (indicating clearly the $(b)$

See the definition of "relevant agreement" in section 9 of the Corporations Act 2001.

• Details of the consideration must include any and all benefits, money and other, that any person from whom a relevant interest was acquired has, or may, become entitled to
  receive in relation to that acquisition. Details m $(5)$ benefit paid on behalf of the substantial holder or its associate in relation to the acquisitions, even if they are not paid directly to the person from whom the relevant interest was acquired.
• The voting shares of a company constitute one class unless divided into separate classes. $(8)$
• Give details, if appropriate, of the present association and any change in that association since the last substantial holding notice. $(7)$